Precipio (PRPO) Competitors $11.07 -0.32 (-2.81%) Closing price 06/11/2025 03:56 PM EasternExtended Trading$11.07 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRPO vs. AKYA, OPXS, OPTX, OMIC, AATC, CLIR, MSAI, DAIO, STAI, and BNGOShould you be buying Precipio stock or one of its competitors? The main competitors of Precipio include Akoya Biosciences (AKYA), Optex Systems (OPXS), Syntec Optics (OPTX), Singular Genomics Systems (OMIC), Autoscope Technologies (AATC), ClearSign Technologies (CLIR), MultiSensor AI (MSAI), Data I/O (DAIO), Scantech AI Systems (STAI), and Bionano Genomics (BNGO). These companies are all part of the "measuring and control equipment" industry. Precipio vs. Its Competitors Akoya Biosciences Optex Systems Syntec Optics Singular Genomics Systems Autoscope Technologies ClearSign Technologies MultiSensor AI Data I/O Scantech AI Systems Bionano Genomics Akoya Biosciences (NASDAQ:AKYA) and Precipio (NASDAQ:PRPO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation, community ranking and risk. Is AKYA or PRPO more profitable? Precipio has a net margin of -17.23% compared to Akoya Biosciences' net margin of -66.77%. Precipio's return on equity of -34.01% beat Akoya Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Akoya Biosciences-66.77% -162.99% -32.76% Precipio -17.23%-34.01%-25.27% Which has better valuation and earnings, AKYA or PRPO? Precipio has lower revenue, but higher earnings than Akoya Biosciences. Precipio is trading at a lower price-to-earnings ratio than Akoya Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAkoya Biosciences$79.96M0.82-$63.32M-$0.97-1.36Precipio$20.03M0.84-$5.85M-$2.07-5.35 Do institutionals and insiders hold more shares of AKYA or PRPO? 79.4% of Akoya Biosciences shares are owned by institutional investors. Comparatively, 10.4% of Precipio shares are owned by institutional investors. 7.3% of Akoya Biosciences shares are owned by company insiders. Comparatively, 16.9% of Precipio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more risk & volatility, AKYA or PRPO? Akoya Biosciences has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500. Comparatively, Precipio has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Do analysts rate AKYA or PRPO? Akoya Biosciences currently has a consensus target price of $2.51, indicating a potential upside of 89.85%. Given Akoya Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Akoya Biosciences is more favorable than Precipio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Akoya Biosciences 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Precipio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer AKYA or PRPO? In the previous week, Precipio had 1 more articles in the media than Akoya Biosciences. MarketBeat recorded 2 mentions for Precipio and 1 mentions for Akoya Biosciences. Akoya Biosciences' average media sentiment score of 1.89 beat Precipio's score of 1.44 indicating that Akoya Biosciences is being referred to more favorably in the media. Company Overall Sentiment Akoya Biosciences Very Positive Precipio Positive Does the MarketBeat Community believe in AKYA or PRPO? Precipio received 237 more outperform votes than Akoya Biosciences when rated by MarketBeat users. Likewise, 73.32% of users gave Precipio an outperform vote while only 55.56% of users gave Akoya Biosciences an outperform vote. CompanyUnderperformOutperformAkoya BiosciencesOutperform Votes3555.56% Underperform Votes2844.44% PrecipioOutperform Votes27273.32% Underperform Votes9926.68% SummaryPrecipio beats Akoya Biosciences on 9 of the 17 factors compared between the two stocks. Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRPO vs. The Competition Export to ExcelMetricPrecipioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.74M$4.59B$5.57B$8.63BDividend YieldN/A0.55%5.28%4.18%P/E Ratio-6.0525.0227.1220.06Price / Sales0.843.89412.30157.10Price / CashN/A36.3438.2534.64Price / Book1.091.677.064.70Net Income-$5.85M-$82.28M$3.23B$247.88M7 Day Performance-2.85%6.12%2.86%2.63%1 Month Performance66.57%11.47%9.07%6.36%1 Year Performance87.63%-11.37%31.45%14.05% Precipio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRPOPrecipio1.6176 of 5 stars$11.07-2.8%N/A+97.0%$16.74M$20.03M-6.0560Positive NewsShort Interest ↓AKYAAkoya Biosciences1.887 of 5 stars$1.25flat$2.51+100.5%-39.7%$62.34M$79.96M-1.0690Positive NewsOPXSOptex Systems2.7269 of 5 stars$8.63+1.2%N/A+31.2%$59.66M$37.43M14.1580Short Interest ↓OPTXSyntec Optics0.5293 of 5 stars$1.59-4.2%N/A-39.8%$58.33M$29.39M0.003Short Interest ↑OMICSingular Genomics SystemsN/A$20.01flat$6.50-67.5%N/A$50.83M$2.91M-0.57220AATCAutoscope Technologies1.3296 of 5 stars$7.55-1.6%N/A+20.9%$41.41M$12.89M8.5840News CoverageShort Interest ↑CLIRClearSign Technologies3.0567 of 5 stars$0.67-1.5%$2.00+198.5%-21.3%$35.12M$2.90M-6.0910Positive NewsMSAIMultiSensor AI3.6635 of 5 stars$0.81+8.7%$2.50+207.5%-66.9%$27.18M$6.30M0.0035Short Interest ↓DAIOData I/O2.3987 of 5 stars$2.78+3.7%$4.00+43.9%+1.8%$25.69M$21.85M-14.63100STAIScantech AI SystemsN/A$0.75+3.1%N/AN/A$19.23M$542.17K0.00N/ABNGOBionano Genomics1.2684 of 5 stars$3.68+0.3%$7.00+90.2%-92.9%$12.38M$28.46M-0.03300 Related Companies and Tools Related Companies Akoya Biosciences Alternatives Optex Systems Alternatives Syntec Optics Alternatives Singular Genomics Systems Alternatives Autoscope Technologies Alternatives ClearSign Technologies Alternatives MultiSensor AI Alternatives Data I/O Alternatives Scantech AI Systems Alternatives Bionano Genomics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRPO) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRPO Stock Free PRPO Stock Alerts